The Key Role of Hepcidin-25 in Anemia in Multiple Myeloma Patients with Renal Impairment
The Key Role of Hepcidin-25 in Anemia in Multiple Myeloma Patients with Renal Impairment
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Anemia is common in multiple myeloma (MM) and is caused by a complex pathomechanism, including impaired iron homeostasis. Our aim is to evaluate the biomarkers of iron turnover: serum soluble transferrin receptor (sTfR) and hepcidin-25 in patients at various stages of MM in relation with markers of anemia, iron status, inflammation, renal impairmen...
Alternative Titles
Full title
The Key Role of Hepcidin-25 in Anemia in Multiple Myeloma Patients with Renal Impairment
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_48f12d794614436aaf2347ee96434d54
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_48f12d794614436aaf2347ee96434d54
Other Identifiers
ISSN
1648-9144,1010-660X
E-ISSN
1648-9144
DOI
10.3390/medicina58030417
